title: Invasive acute hemodynamic response to guide left ventricular lead implantation predicts chronic remodeling in patients undergoing cardiac resynchronization therapy.
abstract: OBJECTIVE
  We evaluated the relationship between acute hemodynamic response (AHR) and reverse remodeling (RR) in cardiac resynchronization therapy (CRT).
  
  
  BACKGROUND
  CRT reduces mortality and morbidity in heart failure patients; however, up to 30% of patients do not derive symptomatic benefit. Higher proportions do not remodel. Multicenter trials have shown echocardiographic techniques are poor at improving response rates. We hypothesized the degree of AHR at implant can predict which patients remodel.
  
  
  METHODS
  Thirty-three patients undergoing CRT (21 dilated and 12 ischemic cardiomyopathy) were studied. Left ventricular (LV) volumes were assessed before and after CRT. The AHR (maximum rate of left ventricular pressure [LV-dP/dt(max)]) was assessed at implant with a pressure wire in the LV cavity. Largest percentage rise in LV-dP/dt(max) from baseline (atrial antibradycardia pacing or right ventricular pacing with atrial fibrillation) to dual-chamber pacing (DDD)-LV was used to determine optimal coronary sinus LV lead position. Reverse remodeling was defined as reduction in LV end systolic volume ≥15% at 6 months.
  
  
  RESULTS
  The LV-dP/dt(max) increased significantly from baseline (801 ± 194 mm Hg/s to 924 ± 203 mm Hg/s, p < 0.001) with DDD-LV pacing for the optimal LV lead position. The LV end systolic volume decreased from 186 ± 68 ml to 157 ± 68 ml (p < 0.001). Eighteen (56%) patients exhibited RR. There was a significant relationship between percentage rise in LV-dP/dt(max) and RR for DDD-LV pacing (p < 0.001). A similar relationship for AHR and RR in dilated cardiomyopathy and ischemic cardiomyopathy (p = 0.01 and p = 0.006) was seen.
  
  
  CONCLUSIONS
  Acute hemodynamic response to LV pacing is useful for predicting which patients are likely to remodel in response to CRT both for dilated cardiomyopathy and ischemic cardiomyopathy. Using AHR has the potential to guide LV lead positioning and improve response rates.
authors: Department of Imaging Sciences, The Rayne Institute, Kings College London, London, United Kingdom. simon.duckett@kcl.ac.uk.
authors: Simon G
authors: SG
authors: Duckett
authors: Matthew
authors: M
authors: Ginks
authors: Anoop K
authors: AK
authors: Shetty
authors: Julian
authors: J
authors: Bostock
authors: Jaswinder S
authors: JS
authors: Gill
authors: Shoaib
authors: S
authors: Hamid
authors: Stam
authors: S
authors: Kapetanakis
authors: Eliane
authors: E
authors: Cunliffe
authors: Reza
authors: R
authors: Razavi
authors: Gerry
authors: G
authors: Carr-White
authors: C Aldo
authors: CA
authors: Rinaldi
mesh_terms: D000368:Aged; D058406:Cardiac Resynchronization Therapy; D058409:Cardiac Resynchronization Therapy Devices; D002311:Cardiomyopathy, Dilated / Q000601:surgery; D005260:Female; D006333:Heart Failure / Q000601:surgery*; D006801:Humans; D008297:Male; D008875:Middle Aged; D019919:Prosthesis Implantation / Q000379:methods*; D016896:Treatment Outcome; D017725:Ventricular Pressure; D020257:Ventricular Remodeling